AnimalModel Market, by Species Type (Rodents (Rats, Mouse, Guinea Pigs andWoodchuck), Rabbits, Monkeys, and Other Species), by Application (ToxicologyStudies, Drug Discovery and Development, Basic and Applied Research, andOthers), by End Users (Academic & Research Institutions, Contract ResearchOrganizations (CROs), and Pharmaceutical companies), and by Region (NorthAmerica, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size,Share, Outlook, and Opportunity Analysis 2018 – 2026
Most of the biomedical researchesare carried on animal model with short-term objective to study toxicity ofdrugs for developing new therapeutics for certain diseases. The main objectiveof using animal model in research is to determine how the animal will respondto the treatment. The anatomical and physiological similarities between humansand animals help the researchers to investigate novel therapies in animal modelsbefore applying it on humans. The use of animal model in research is based onfact that human diseases can affect other animal species. It is not onlylimited for infectious diseases but also for common diseased conditionsincluding diabetes, hypertension, cancer, epilepsy, and others.
Animal Model Market Outlook
Increasing number of researchbased on animal test to develop novel drugs is a major factor that boosts theanimal model market growth. For instance, as per data reported in AnnualStatistics of Scientific Procedures on Living Animals, about 3.79 millionscientific procedures were carried out on protected living animals in GreatBritain in 2017.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2488
Moreover, as per data inWorldwide Animal Research Statistics, in 2016, 3,789,373 vertebrates perprocedure and 110,553 mammals per procedure (excluding rats and mice) have beenused in research experiments conducted in the U.S.
However, rising concern foranimal welfare by social and government organizations leads to use lessernumber of animals in research purpose, which may hamper growth of the animalmodel market.
Animal Model Market RegionalAnalysis
On the basis of region, theglobal animal model market is segmented into North America, Latin America,Europe, Asia Pacific, Middle East, and Africa.
Geographically, North America isexpected to witness conducive growth for animal model market, owing to highpresence of major market players in this region. For instance, in September2018, Taconic Biosciences, a U.S. based company providing geneticallyengineered rodent model solutions, announced partnership plans with GovernmentScientific Source (GSS) to become the first animal model provider on generalservices administration contract schedule. Taconic Bioscience’s products arefit into GSS effort to support biomedical research solutions within the U.S.federal government.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/animal-model-market-2488
Moreover, in November 2018,Jackson Laboratory, an independent, nonprofit biomedical research institutionheadquartered in Maine, the U.S., established a dedicated quarantine facilityfor the importation of JAX Mice into China. Thus, expansion of facilities bymanufacturers in Asia Pacific is expected to show high growth of the marketduring the forecast period.
Increasing use of animal modelsin research for developing vaccines is another major factor, which will showsignificant growth for animal model market in Europe. For instance, in November2018, in the workshop organized by EDUFLUVAC consortium, a European Unionfunded project, coordinated by the European Vaccine Initiative, experts frominfluenza vaccine community gathered to discuss the current knowledge andfuture perspectives for testing broadly reactive influenza vaccines in animalmodels. The workshop has been organized for summarizing the outcome of“Experimental animal models for universal influenza vaccines” project.
Key players in the animal modelmarket include Charles River Laboratories International, Inc., HorizonDiscovery Group plc, The Jackson Laboratory, Trans Genic Inc, TaconicBiosciences, Inc., Genoway SA, Eurofins Scientific SE, Crown Bioscience, Inc.,Harbour Antibodies BV, Envigo CRS SA, Ingenious Targeting Laboratory, andTransposagen Biopharmaceuticals, Inc.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2488
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
